- Home
- NEGG vs IMRX Comparison
NEGG vs IMRX Comparison
Compare NEGG & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- IMRX
- Stock Information
- Founded
- NEGG 2001
- IMRX 2008
- Country
- NEGG United States
- IMRX United States
- Employees
- NEGG N/A
- IMRX N/A
- Industry
- NEGG Other Specialty Stores
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- NEGG Consumer Discretionary
- IMRX Health Care
- Exchange
- NEGG Nasdaq
- IMRX Nasdaq
- Market Cap
- NEGG 122.3M
- IMRX 145.7M
- IPO Year
- NEGG 2010
- IMRX 2021
- Fundamental
- Price
- NEGG $36.22
- IMRX $4.17
- Analyst Decision
- NEGG
- IMRX Strong Buy
- Analyst Count
- NEGG 0
- IMRX 4
- Target Price
- NEGG N/A
- IMRX $13.25
- AVG Volume (30 Days)
- NEGG 720.9K
- IMRX 3.2M
- Earning Date
- NEGG 08-28-2025
- IMRX 08-05-2025
- Dividend Yield
- NEGG N/A
- IMRX N/A
- EPS Growth
- NEGG N/A
- IMRX N/A
- EPS
- NEGG N/A
- IMRX N/A
- Revenue
- NEGG $1,235,576,000.00
- IMRX N/A
- Revenue This Year
- NEGG N/A
- IMRX N/A
- Revenue Next Year
- NEGG N/A
- IMRX N/A
- P/E Ratio
- NEGG N/A
- IMRX N/A
- Revenue Growth
- NEGG N/A
- IMRX N/A
- 52 Week Low
- NEGG $3.32
- IMRX $1.00
- 52 Week High
- NEGG $56.00
- IMRX $4.60
- Technical
- Relative Strength Index (RSI)
- NEGG 68.80
- IMRX 68.17
- Support Level
- NEGG $15.31
- IMRX $3.31
- Resistance Level
- NEGG $56.00
- IMRX $4.60
- Average True Range (ATR)
- NEGG 5.67
- IMRX 0.45
- MACD
- NEGG 2.67
- IMRX 0.07
- Stochastic Oscillator
- NEGG 56.85
- IMRX 79.72
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.